Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Grants Accelerated Approval to Lynozyfic (linvoseltamab-gcpt) for Treatment of Relapsed or Refractory Multiple Myeloma

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic...

4 days ago New Drug Approvals

Takeda Announces U.S. FDA Approval of Gammagard Liquid ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content

OSAKA, Japan and CAMBRIDGE, Massachusetts, June 30, 2025 – Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration...

6 days ago New Drug Approvals

Screen Time May Slow Learning Skills, Study Finds

SATURDAY, July 5, 2025 — Screens are a part of daily life for many families — but too much screen time in the early years could slow a child’s...

today Medical

Is One Type of Water Healthier Than Another? Here’s What Experts Say

SUNDAY, July 6, 2025 — Alkaline. Electrolyte. Flavored. Walk down the beverage aisle and you’ll find all kinds of waters promising extra health...

yesterday Medical

Health Care Expenditure Expected to Top GDP Growth 2024 to 2033

The annual growth in national health spending is expected to be faster than average gross domestic product (GDP) growth during 2024 to 2033, according...

3 days ago News for Health Professionals

Measles Outbreak in Kentucky Confirmed

There has been nationwide total of 1,267 confirmed cases of measles this year, with Kentucky being the latest state to announce an outbreak, the U.S. Centers...

3 days ago Medical

Weight Loss Continues Five Years After Tummy Tucks

Patients undergoing abdominoplasty experience continued weight loss up to five years postoperatively, according to a study published in the July issue...

3 days ago News for Health Professionals

Considerable Variation Seen in Commercial Pricing for Surgery Services

Commercial pricing varies considerably for general surgery services, with facility prices exhibiting greater variability, according to a research letter...

3 days ago News for Health Professionals

Greater Neighborhood Disadvantage Tied to Inflammatory, Alzheimer Disease Biomarkers

Greater neighborhood disadvantage is associated with increased inflammatory and Alzheimer disease (AD) cerebrospinal fluid (CSF) biomarkers in older adults,...

3 days ago News for Health Professionals

Hearing Aids Are a Boon To Social Life, Study Finds

THURSDAY, July 3, 2025 — Some folks won’t use hearing aids because they’re worried the devices will make them look old or get in the...

3 days ago Medical

Want More Exercise? Go To Bed Earlier, Study Suggests

THURSDAY, July 3, 2025 — The age-old “early to bed, early to rise” proverb applies to your daily exercise regimen as well as your health,...

3 days ago Medical

Hemispherian Receives U.S. FDA Orphan Drug Designation for GLIX1 for the Treatment of Malignant Glioma

Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced today that the U.S. Food and Drug...

6 days ago Clinical Trials

Monthly News Roundup - June 2025

Dupixent Approved in the U.S. as the First Targeted Medicine to Treat Patients with Bullous Pemphigoid Dupixent (dupilumab) has been approved for the...

6 days ago News for Health Professionals

FDA Requires Expanded Labeling About Weight Loss Risk in Patients Younger Than 6 Years Taking Extended-Release Stimulants for ADHD

FDA Drug Safety Communication - June 30, 2025 What safety concern is FDA announcing?The U.S. Food and Drug Administration (FDA) is revising the labeling...

6 days ago FDA Alerts

Amgen Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-line Gastric Cancer

THOUSAND OAKS, Calif., June 30, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Phase 3 FORTITUDE-101 clinical trial...

6 days ago Clinical Trials

Unicycive Therapeutics Announces Receipt of Complete Response Letter for Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

6 days ago New Drug Applications

Recently Added

Recently added consumer and prescribing information: Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma

For Consumers

For Professionals

For Researchers

Pharmaceutical Company Directory

Latest FDA New Drug Approvals

Lynozyfic Lynozyfic (linvoseltamab-gcpt) is a bispecific B-cell maturation antigen (BCMA)‑directed CD3 T-cell engager for the treatment of relapsed o...
Harliku Harliku (nitisinone) is a hydroxyphenyl-pyruvate dioxygenase inhibitor indicated for the reduction of urine homogentisic acid in adult...
Yeztugo Yeztugo (lenacapavir) is a human immunodeficiency virus type 1 (HIV-1) capsid inhibitor for pre‑exposure prophylaxis (PrEP) to reduce the r...

More FDA approvals

Drug Information

Tools

News & Alerts

Professionals

Top 100 Drugs

Recommended Content

Find Drugs & Conditions

FDA Requires Expanded Labeling About Weight Loss Risk in Patients Younger Than 6 Years Taking Extended-Release Stimulants for ADHD

FDA Grants Accelerated Approval to Lynozyfic (linvoseltamab-gcpt) for Treatment of Relapsed or Refractory Multiple Myeloma

Screen Time May Slow Learning Skills, Study Finds

Recently Added

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

Drug Information

Tools

News & Alerts

Professionals

Top 100 Drugs